BiotechPark with Innovation- and Incubationscenter

diagram

Berlin-Buch, with its long tradition of excellent biomedical basic and clinical research as well as clinical expertise, is an ideal environment for life science companies. The campus atmosphere is conducive to scientific exchange, technology transfer and collaborative projects.

With an area of approximately 45,000 m², the BiotechPark Berlin-Buch is one of the largest biotech parks in Germany. Here entrepreneurs and companies find affordable, industry-specific laboratory and office space with state-of-the-art facilities. Start-ups can grow and thrive in the Innovation and Incubation Center, building areas on the Campus allow for future development. The managing company, Campus Berlin-Buch GmbH, supports the companies in all matters and provides comprehensive service.
Currently, 75 companies are located on campus and employ around 850 people. More than fifty of these companies are in the biotech sector, several others offer services for the life science industry. Since 1998 the number of employees of the biotech companies has more than doubled.

The business fields of the companies range from medical technology products, molecular biological diagnostics and treatments, preclinical pharmacological and pharmacogenomic tests, RNA technologies, the search for pharma-relevant target molecules, production and testing of drugs and the analysis and synthesis of biomolecules.

From 2023 the new BerlinBioCube start-up center in BiotechPark Berlin-Buch will offer an additional 8,000 square meters of laboratory and office space and attractive services for start-ups in the fields of biotechnology and medical technology as well as adjacent areas.

„Made in Buch“ stands for high quality and innovation in the life sciences. Selected products can be found here.

Otto Warburg House

News innovation

Talk im Cube: Financing Models for Biotechs

We are excited to invite to a further engaging panel discussion focused on the critical topic of financing models in biotechnology companies. Join us as we explore the various funding strategies that ...

more ...

Eckert & Ziegler and GlyTherix Sign Agreement for Lutetium-177 Supply

Eckert & Ziegler (ISIN DE0005659700, SDAX) and GlyTherix Ltd (GlyTherix), an Australian targeted radiotherapy company specialising in developing antibody radiopharmaceuticals for solid tumors, today a...

more ...

Eckert & Ziegler: Spin-off of Pentixapharm AG Registered with the Commercial Register

Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) announces that the spin-off resolution approved at the Annual General Meeting on 26 June 2024 was entered in the commercial register of the Charlottenbu...

more ...

Events Campus

22.11.2024, 19:00
Der Jeanne Mammen Salon „Aufbruch“

Anlässlich des 134. Geburtstags der Berliner Künstlerin lassen wir am 22. November 2024 ab 19:00 Uhr im Jeanne Mammen Saal im Torhaus des Campus Berlin-Buch die Tradition der Berliner Salonabende wied...

more ...

26.11.2024, 18:00
Campuskino: "Séraphine", ein Film von Martin Provost (Frankreich 2008)

Der Freundeskreis des Max Delbrück Center lädt ein zum Campuskino

more ...

28.11.2024, 17:00
Talk im Cube: Financing Models for Biotechs

We are excited to invite to a further engaging panel discussion focused on the critical topic of financing models in biotechnology companies. Join us as we explore the various funding strategies that ...

more ...

Sponsoren der Website: